On November 16, 2023, China Reform Health Management and Services Group Co., Ltd. closed the transaction. The company has now issued 80,413,268 A shares at an issue price of CNY 9.88 per share for the gross proceeds of CNY 794,483,087.84. The company has paid issuance expenses of CNY 11,990,814.44 & net proceeds will be CNY 782,492,273.36.

Prior to issuance, as of the end of September 2023, Pan Guozheng owns 3,008,600 shares in the company, accounting for 0.33% stake. After the issuance, China Reform Development Investment Management Co., Ltd. owns 24,123,980 shares accounting for 2.45% stake, Nuode Fund Management Co., Ltd. owns 20,460,526 shares accounting for 2.08% stake, Caitong Fund Management Co., Ltd. owns 9,159,919 shares accounting for 0.93% stake, UBS AG owns 7,995,951 shares accounting for 0.81% stake, Zhuang Fengjuan owns 6,715,782 shares accounting for 0.68% stake, Pan Guozheng owns 6,045,037 shares accounting for 0.61% stake. The transaction included participation from new investors China Reform Development Investment Management Co., Ltd. for 24,123,980 shares for CNY 238,344,922.40, Nuode Asset Management Co., Ltd. for 20,460,526 shares for CNY 202,149,996.88, Caitong Fund Management Co., Ltd. for 9,159,919 shares for CNY 90,499,999.72, UBS AG for 7,995,951 shares for CNY 78,999,995.88, Zhuang Fengjuan for 4,048,582 shares for CNY 39,999,990.16, Pan Guozheng for 3,036,437 shares for CNY 29,999,997.56, Dong Weiguo for 2,530,364 shares for CNY 24,999,996.32, China Securities Co., Ltd. for 2,226,720 shares for CNY 21,999,993.60, Taikang Asset Management Co., Ltd. for 2,024,291 shares for CNY 19,999,995.08, China Asset Management Co.

Ltd. for 1,720,647 shares for CNY 16,999,992.36, Aegon-Industrial Fund Management Co., Ltd. for 1,720,647 shares for CNY 16,999,992.36 and Wuhe Liangdao Health Pilot Private Securities Investment Fund managed by Zhuhai Wuhe Asset Management Partnership Enterprise (Limited Partnership) for 1,365,204 shares for CNY 13,488,215.52.